Congratulations to George Warimwe for being conferred the title full Professor of Vaccinology at the University of Oxford. “I’m truly honoured by this recognition. It is testimony to the excellent mentorship received over the years and the immense contribution to vaccine R&D in Africa by the team of amazingly talented scientists that work with me […]

Read more about our Community and Public Engagement Strategy here: https://kemri-wellcome.org/wp-content/uploads/2022/07/Community-and-Publication-Engagement-brief.pdf

Summary We applied models that predicted the pattern of the first peak of COVID-19 cases in late July 2020 but did not predict the second peak in November 2020. The peak in November 2020 can be explained by now adding to the model: a) data that has become available on negative test numbers; b) an […]

Health system responsiveness, defined as how the health system reacts to input from the public or citizens is one of the goals of the health system alongside fairness in financing and health service outcomes. Listening to and responding to public inputs and feedback can lead to a health system that is stronger and fairer to […]

Vitamin D deficiency is an important public problem worldwide because of its link to many diseases and poor health outcomes. However, there is limited data on the vitamin D status of African populations. We aimed to determine the prevalence and risk factors associated with vitamin D deficiency in Africa. To achieve this, we searched for, […]

[PRESS RELEASE] Brazzaville, 23 November 2020 – The World Health Organization (WHO) and partners launched an online platform today to promote the exchange of evidence and experience across countries in the African region. By working to foster evidence-informed decision-making in an endeavor to re-engineer health service delivery, the initiative is expected to drive countries’ health […]

Kenya has joined the global efforts in search of an effective vaccine for COVID-19 with the start of a trial evaluating a leading COVID-19 vaccine candidate ChAdOx1 nCoV-19. The trial team has vaccinated its first volunteers after receiving the necessary regulatory and ethical approvals, as well as the national ministry of health, and Kilifi county […]

Despite increased efforts at global, regional, and country level to promote gender equality, women continue to be under-represented in leadership positions across a range of sectors and geographic regions. In the health sector specifically, women comprise a substantial proportion of the global health workforce. However, women are over-represented in lower-paying, lower-status occupations and their representation […]

1. Je majaribio ya chanjo ya ChAdOx1 nCOV-19 ni nini? Majaribio haya yanalenga kutathmini ikiwa chanjo ya ChAdOx1 nCOV-19 ni salama, inafanya kazi na inapeana kinga dhidi ya COVID-19 kwa watu wazima wenye umri wa miaka 18 na zaidi 2. Majaribio ya chanjo hii yatachukuwa muda gani? Baada ya kuanza, majaribio yatafanyika kwa muda wa miezi 24. […]

1. What is the ChAdOx1 Vaccine Trial? This trial aims to assess whether the ChAdOx1 vaccine is safe, effective and provides immunity against COVID-19 in adults aged 18 years and above. 2. How long will the vaccine trial run? After starting, the trial will run for 24 months. 3. Why conduct the trial in Kenya? A vaccine which […]